Can Anti-Müllerian Hormone (AMH) levels be increased?

Anti-Müllerian hormone (AMH) testing provides a reliable and rapid assessment of ovarian reserve function. It estimates the number of antral follicles potentially available in a woman’s ovaries, thereby offering insight into her reproductive capacity and the likely timing of menopause. So, can AMH levels be increased? Below, we address this question.

Can Anti-Müllerian Hormone Levels Be Increased?

Yes, AMH levels can be modulated. The normal reference range for AMH is 2–7 ng/mL. Levels between 0.7–2 ng/mL suggest diminished ovarian reserve or poor ovarian response. Levels exceeding 7 ng/mL may indicate granulosa cell tumor, polycystic ovary syndrome (PCOS), or ovarian hyperstimulation syndrome (OHSS). Treatment strategies should be tailored according to individual test results. Currently, multiple therapeutic options exist: ovulation induction therapy may be employed; for women seeking fertility, hormone replacement therapy (HRT) may be considered; additionally, gonadotropin-based medications can promote oocyte maturation and release to achieve conception. In mild cases, psychological support and maintaining an optimistic outlook may also be beneficial.

Knowledge Expansion: What Are the Symptoms of Premature Ovarian Insufficiency (POI)?

1. Abnormal Vaginal Discharge

POI may cause abnormal vaginal discharge—typically yellowish in color and accompanied by an unpleasant odor. Some women may also develop pyometra (pus accumulation in the uterine cavity). Additionally, menstrual irregularities commonly occur, including shortened menstrual cycles, reduced menstrual flow, or even amenorrhea.

2. Emotional Disturbances

POI can lead to emotional instability, such as irritability and heightened emotional reactivity. Other associated symptoms include hot flashes, excessive sweating, facial flushing, and decreased libido. If these symptoms arise, prompt evaluation of sex hormone levels—including follicle-stimulating hormone (FSH) and luteinizing hormone (LH)—at a medical facility is recommended to assess for possible POI.

3. Menopausal-like Symptoms

Women with POI may experience a constellation of symptoms resembling natural menopause. Common manifestations include osteoporosis and body composition changes—such as generalized pain and increased abdominal and lumbar fat deposition. Moreover, POI leads to progressive decline in ovarian function, potentially culminating in ovarian atrophy and consequent infertility.

The above outlines whether AMH levels can be increased. We hope this information proves helpful.